Loading stock data…
TECH
$55.02-0.30 (-0.54%)
Market ClosedLast close May 1
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bio-Techne Corporation in the Healthcare sector is trading at $55.02. The stock is currently 24% below its 52-week high of $72.16, remaining 5.2% below its 200-day moving average. Technical signals show neutral RSI of 45 and bearish MACD signal, explaining why TECH maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 45) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$55.02
Potential Downside
83.1%
Whystock Fair Value$9.32
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus11 analysts
Buy
Mean target$72.27+31.4%
Range$54.00 – $80.00
Fundamentals
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.17B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
110.53
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.49
Div Yield
Strong income play. Yield provides a meaningful total return floor.
55.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
3.65%
Volume
Today's trading volume
1.95M
Recent News
Bio-Techne's Q3 Earnings on Deck: What's in Store for the Stock?
TECH gears up for Q3 results with modest revenue growth expected as biotech funding trends and product momentum shape the outlook.
3 Small-Cap Stocks That Fall Short
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
1 Profitable Stock to Target This Week and 2 We Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
1 S&P 500 Stock to Own for Decades and 2 We Question
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Bio-Techne Reorganizes Brand To Link Research Spatial And Diagnostics Workflows
Bio-Techne Corporation (NasdaqGS:TECH) is rolling out a new brand architecture centered on three portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. The updated structure is designed to align with modern research and clinical workflows and is set to be introduced at upcoming scientific conferences. The move is intended to simplify how customers access products and clarify the role of each offering across discovery, spatial analysis, and diagnostics. For you as...